215 results
Page 2 of 11
8-K
EX-99.1
le8edo
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
e3vi6psus0t8dyd
24 Jul 23
VBI Vaccines Announces Closing of Underwriters’ Partial Exercise of Option to Purchase Additional Common Shares
8:00am
424B5
i33qmczxqsmkyerxh gr
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
l592 6kqw
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
6j8gz5 dp
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-99.2
c0eddkg umfpan
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
cqvxg56 5bdv
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
agcy3b0usfxqu1vw
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
3zckc1z9p0o
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
8ktlpcb09xnh 5t
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
br2du696iezk0gxiau
15 Jun 23
VBI Vaccines Announces PreHevbri® is Now Available in the United Kingdom for the Prevention of Hepatitis B in Adults
8:00am
8-K
EX-99.1
3rpr2 ft8g
7 Jun 23
VBI Vaccines Announces Poster Presentation at EASL 2023
8:00am
8-K
EX-99.1
b18hbo7xszuhlr
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
k19zlybwfw 41kpur
25 Apr 23
VBI Vaccines Appoints Vaughn Himes to Board of Directors
8:00am
8-K
EX-99.1
x730wdgi
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-99.1
milt bkbbu1fcwa1w
8 Dec 22
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
8:00am
8-K
EX-99.1
vujzx c0ksfz8r8f
6 Dec 22
Entry into a Material Definitive Agreement
9:25am